{{Rsnum
|rsid=1446109
|Gene=CTNNA2
|Chromosome=2
|position=80311294
|Orientation=plus
|GMAF=0.1561
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CTNNA2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 74.3 | 25.7 | 0.0
| HCB | 49.6 | 46.7 | 3.6
| JPT | 36.6 | 45.5 | 17.9
| YRI | 79.6 | 19.7 | 0.7
| ASW | 87.7 | 12.3 | 0.0
| CHB | 49.6 | 46.7 | 3.6
| CHD | 62.4 | 33.0 | 4.6
| GIH | 90.1 | 8.9 | 1.0
| LWK | 90.0 | 9.1 | 0.9
| MEX | 69.0 | 31.0 | 0.0
| MKK | 84.6 | 15.4 | 0.0
| TSI | 88.2 | 10.8 | 1.0
| HapMapRevision=28
}}{{PMID|17667961|OA=1
}} having minor alleles at all 3 of [[rs1446109]]-[[rs1007371]]-[[rs723524]] may affect [[left]]-right asymmetrical brain function, such as handedness, and much of human cognition, behavior and emotion. [https://genepi.qimr.edu.au/contents/p/staff/CV522.pdf pdf full paper]

{{PMID|19416921|OA=1
}} Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}